PMC:7283670 / 38947-39119 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T16360","span":{"begin":88,"end":93},"obj":"Body_part"},{"id":"T80880","span":{"begin":95,"end":101},"obj":"Body_part"}],"attributes":[{"id":"A37722","pred":"fma_id","subj":"T16360","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A88648","pred":"fma_id","subj":"T80880","obj":"http://purl.org/sig/ont/fma/fma228738"}],"text":"45.8 ± 14/31 males (77.1%) and 17 females (22.9%) Real‐time RT‐PCR, CT, GLMs analysis Serum, throat‐swab specimens Laboratory confirmed cases Spectrum of disease: mild:"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T70","span":{"begin":88,"end":93},"obj":"Body_part"},{"id":"T71","span":{"begin":95,"end":101},"obj":"Body_part"}],"attributes":[{"id":"A70","pred":"uberon_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A71","pred":"uberon_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/UBERON_0000341"}],"text":"45.8 ± 14/31 males (77.1%) and 17 females (22.9%) Real‐time RT‐PCR, CT, GLMs analysis Serum, throat‐swab specimens Laboratory confirmed cases Spectrum of disease: mild:"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T355","span":{"begin":13,"end":18},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T356","span":{"begin":13,"end":18},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T357","span":{"begin":34,"end":41},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"}],"text":"45.8 ± 14/31 males (77.1%) and 17 females (22.9%) Real‐time RT‐PCR, CT, GLMs analysis Serum, throat‐swab specimens Laboratory confirmed cases Spectrum of disease: mild:"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T364","span":{"begin":0,"end":172},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"45.8 ± 14/31 males (77.1%) and 17 females (22.9%) Real‐time RT‐PCR, CT, GLMs analysis Serum, throat‐swab specimens Laboratory confirmed cases Spectrum of disease: mild:"}